[pending] HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)
Pending LLM rewrite. Source: FDA_DRUG D-0357-2025.
- Product
- HALOPERIDOL DECANOATE — HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)
- Category
- Drug
- Distribution
- Distributed nationwide
State
19,789 recalls have nationwide distribution and so reach Virginia. 0 additional recalls listed Virginia specifically in their distribution scope.
Most US product recalls have nationwide distribution — the manufacturer ships into every state and the recall sweeps the same way. We include those in this listing because they affect Virginia consumers even though the source notice doesn’t name the state. State-specific recalls are usually for products with regional distribution (a regional dairy, a local store brand) or where the agency was able to narrow the affected shipments to specific destinations.
If you’re checking whether a recall affects your purchase, the recall detail page lists the exact production lot codes, UPCs, and best-by dates. Match those against your package — distribution scope is a starting filter, not the final answer.
Pending LLM rewrite. Source: FDA_DRUG D-0357-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0333-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-1546-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0351-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0319-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0359-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0355-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-1549-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0322-2025.
Pending LLM rewrite. Source: FDA_DEVICE Z-1543-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0321-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0341-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0346-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0331-2025.
Pending LLM rewrite. Source: FDA_FOOD F-0701-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0342-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0311-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0336-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0353-2025.
Medline is recalling 20 units of ReNewal Coblator II ENT devices because drip chambers may disconnect from saline tubing under tension, potentially disrupting fluid delivery during procedures.
Pending LLM rewrite. Source: FDA_DRUG D-0330-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0361-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0325-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0349-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0327-2025.